Editorial: It Is Not a Wide-Open Field for Incretins - Collateral Benefits Favour the Use of Metformin in Advanced Non-Alcoholic Steatohepatitis

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Editorial: Treatments for Non-Alcoholic Steatohepatitis - Still a Long Way to Go

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Treating the Liver to Treat the Kidney in Non-Alcoholic Steatohepatitis - Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2009English

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

PLoS ONE
Multidisciplinary
2010English

Modern Morphological Characteristics of Alcoholic, Non-Alcoholic and Toxic Steatohepatitis

Bukovinian Medical Herald
2019English

Cholesterol Metabolism and the Pathogenesis of Non-Alcoholic Steatohepatitis

Progress in Lipid Research
BiochemistryCell Biology
2013English

Metformin Use During Pregnancy: Is It Really Safe?

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

MLK3 as a Regulator of Disease Progression in Non-Alcoholic Steatohepatitis

Liver International
Hepatology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy